Abiopharma

News list

Levy Adam Scott 🔴 sold 10.8K shares of Mineralys Therapeutics, Inc. (MLYS) at $32.14 Transaction Date: Jan 12, 2026 | Filing ID: 000002

Full text

News bot Jan. 29, 2026, 2:26 p.m.
🔍 Levy Adam Scott (Executive)

Company: Mineralys Therapeutics, Inc. (MLYS)

Report Date: 2026-01-12
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 10,758
Detailed Transactions and Holdings:
- Sold 10,758 shares of Common Stock at $32.1364 per share (Direct)
  Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,638.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023.
- F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.90 to $32.37. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.